Maryam Peymani | Parkinson | Best Researcher Award

Dr. Maryam Peymani | Parkinson | Best Researcher Award

Islamic Azad University | Iran

Dr. Maryam Peymani is an Iranian molecular geneticist from Isfahan who has built a distinguished academic career within the Department of Biology at the Islamic Azad University, Shahrekord branch, where she serves as an Associate Professor and has also contributed as a research director. With a strong educational foundation spanning genetics and molecular genetics, her academic training focused on the roles of PPARγ in cellular differentiation, which later shaped her extensive work in stem cell biology, transcriptomics, neurodegeneration, and cancer biology. Her research interests encompass cellular and molecular mechanisms, human stem cell applications, signal transduction under stress, bioinformatics, and the transcriptomic landscape of complex diseases, supported by strong skills in molecular techniques, stem cell culture, real-time PCR, cloning, Western blotting, and advanced RNA-based analyses. She has participated in diverse laboratory projects involving embryonic stem cell differentiation, neural and mesodermal pathways, inflammatory models, cardiotoxicity studies, and comprehensive bioinformatics evaluations. Recognised as a top researcher at reputable scientific institutions, she has demonstrated consistent excellence and leadership. Through a prolific publication record and dedication to mentoring students, Dr. Peymani continues to advance research in molecular genetics, contributing meaningful insights to biomedical science while fostering innovation and scientific growth.

Profile: ORCID

Featured Publications

Amiri, S., Gholizadeh, L., Rasti, A., Peymani, M., Mirjalili, S. A. M., Vahidi, S., & Kalantar, S. M. (2024). Comparison of SPAG11A gene expression in infertile men with grade 1 and grade 2 varicocele before and after treatment. JBRA Assisted Reproduction.

Hassani, M., Mahdevar, M., & Peymani, M. (2024). Exploring the role of interleukin 11 in cancer progression, patient survival, and therapeutic insights. Molecular Biology Reports.

Golozar, M., Valipour Motlagh, A., Mahdevar, M., Peymani, M., InanlooRahatloo, K., & Ghaedi, K. (2024). TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers. Experimental and Molecular Pathology.